Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Elemento Lab
Explore this Website
Home
Affiliations
Research
Toggle Research menu options
Big Data Analytics & Machine Learning
Cancer Genomics
Drug Discovery
Epigenomics
Genetics
Mathematical Modeling
Projects
Proteomics
Spatial Computing
Software
Lab Team
Publications
News
Join Us
Weill Cornell Medicine
Care
Discover
Teach
Home
Affiliations
Research
Lab Team
Publications
News
Join Us
Home
Publications
Publications
Found 34 results
Author
Title
Type
Year
Filters:
Author
is
Rubin, Mark A
[Clear All Filters]
2021
Sugita M
,
Wilkes DC
,
Bareja R
,
Eng KW
,
Nataraj S
,
Jimenez-Flores RA
,
Yan LB
,
De Leon JPauline
,
Croyle JA
,
Kaner J
et al.
. 2021.
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia.
.
NPJ Precis Oncol. 5(1):44.
2020
Vosoughi A
,
Zhang T
,
Shohdy KS
,
Vlachostergios PJ
,
Wilkes DC
,
Bhinder B
,
Tagawa ST
,
Nanus DM
,
Molina AM
,
Beltran H
et al.
. 2020.
Common germline-somatic variant interactions in advanced urothelial cancer.
.
Nat Commun. 11(1):6195.
Pisapia DJ
,
Ohara K
,
Bareja R
,
Wilkes DC
,
Hissong E
,
Croyle JA
,
Kim J-H
,
Saab J
,
MacDonald TY
,
Beg S
et al.
. 2020.
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.
.
Acta Neuropathol Commun. 8(1):80.
Liu D
,
Shoag JE
,
Poliak D
,
Goueli RS
,
Ravikumar V
,
Redmond D
,
Vosoughi A
,
Fontugne J
,
Pan H
,
Lee D
et al.
. 2020.
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.
.
Nat Commun. 11(1):1987.
Park K
,
Tran H
,
Eng KW
,
Ramazanoglu S
,
Rolon RMMarrero
,
Scognamiglio T
,
Borczuk A
,
Mosquera JMiguel
,
Pan Q
,
Sboner A
et al.
. 2020.
Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.
.
Arch Pathol Lab Med.
Auguste A
,
Blanc-Durand F
,
Deloger M
,
Le Formal A
,
Bareja R
,
Wilkes DC
,
Richon C
,
Brunn B
,
Caron O
,
Devouassoux-Shisheboran M
et al.
. 2020.
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond Mutations: A Comprehensive Genomic Analysis.
.
Cells. 9(6)
2019
Fernandez EM
,
Eng K
,
Beg S
,
Beltran H
,
Faltas BM
,
Mosquera JMiguel
,
Nanus DM
,
Pisapia DJ
,
Rao RA
,
Robinson BD
et al.
. 2019.
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution.
.
JCO Precis Oncol. 3
Augello MA
,
Liu D
,
Deonarine LD
,
Robinson BD
,
Huang D
,
Stelloo S
,
Blattner M
,
Doane AS
,
Wong EWP
,
Chen Y
et al.
. 2019.
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
.
Cancer Cell. 35(4):603-617.e8.
Augello MA
,
Liu D
,
Deonarine LD
,
Robinson BD
,
Huang D
,
Stelloo S
,
Blattner M
,
Doane AS
,
Wong EWP
,
Chen Y
et al.
. 2019.
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
.
Cancer Cell. 35(5):817-819.
Sailer V
,
Eng KWa
,
Zhang T
,
Bareja R
,
Pisapia DJ
,
Sigaras A
,
Bhinder B
,
Romanel A
,
Wilkes D
,
Sticca E
et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Robinson BD
,
Vlachostergios PJ
,
Bhinder B
,
Liu W
,
Li K
,
Moss TJ
,
Bareja R
,
Park K
,
Tavassoli P
,
Cyrta J
et al.
. 2019.
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling.
.
Nat Commun. 10(1):2977.
2018
Sailer V
,
Schiffman MH
,
Kossai M
,
Cyrta J
,
Beg S
,
Sullivan B
,
Pua BB
,
Lee KSteve
,
Talenfeld AD
,
Nanus DM
et al.
. 2018.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
.
Cancer. 124(5):1008-1015.
Puca L
,
Bareja R
,
Prandi D
,
Shaw R
,
Benelli M
,
Karthaus WR
,
Hess J
,
Sigouros M
,
Donoghue A
,
Kossai M
et al.
. 2018.
Patient derived organoids to model rare prostate cancer phenotypes.
.
Nat Commun. 9(1):2404.
Lundquist MR
,
Goncalves MD
,
Loughran RM
,
Possik E
,
Vijayaraghavan T
,
Yang A
,
Pauli C
,
Ravi A
,
Verma A
,
Yang Z
et al.
. 2018.
Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.
.
Mol Cell. 70(3):531-544.e9.
Dominguez PM
,
Ghamlouch H
,
Rosikiewicz W
,
Kumar P
,
Béguelin W
,
Fontán L
,
Rivas MA
,
Pawlikowska P
,
Armand M
,
Mouly E
et al.
. 2018.
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.
.
Cancer Discov. 8(12):1632-1653.
2017
Huang L
,
Fernandes H
,
Zia H
,
Tavassoli P
,
Rennert H
,
Pisapia D
,
Imielinski M
,
Sboner A
,
Rubin MA
,
Kluk M
et al.
. 2017.
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations.
.
J Am Med Inform Assoc. 24(3):513-519.
Romanel A
,
Garritano S
,
Stringa B
,
Blattner M
,
Dalfovo D
,
Chakravarty D
,
Soong D
,
Cotter KA
,
Petris G
,
Dhingra P
et al.
. 2017.
Inherited determinants of early recurrent somatic mutations in prostate cancer.
.
Nat Commun. 8(1):48.
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized and Cancer Models to Guide Precision Medicine.
.
Cancer Discov. 7(5):462-477.
2016
Faltas BM
,
Prandi D
,
Tagawa ST
,
Molina AM
,
Nanus DM
,
Sternberg C
,
Rosenberg J
,
Mosquera JMiguel
,
Robinson B
,
Elemento O
et al.
. 2016.
Clonal evolution of chemotherapy-resistant urothelial carcinoma.
.
Nat Genet. 48(12):1490-1499.
Gayvert KM
,
Dardenne E
,
Cheung C
,
Boland MRegina
,
Lorberbaum T
,
Wanjala J
,
Chen Y
,
Rubin MA
,
Tatonetti NP
,
Rickman DS
et al.
. 2016.
A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors.
.
Cell Rep. 15(11):2348-56.
Rennert H
,
Eng K
,
Zhang T
,
Tan A
,
Xiang J
,
Romanel A
,
Kim R
,
Tam W
,
Liu Y-C
,
Bhinder B
et al.
. 2016.
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
.
NPJ Genom Med. 1
Beltran H
,
Prandi D
,
Mosquera JMiguel
,
Benelli M
,
Puca L
,
Cyrta J
,
Marotz C
,
Giannopoulou E
,
Chakravarthi BVSK
,
Varambally S
et al.
. 2016.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
.
Nat Med. 22(3):298-305.
Pritchard CC
,
Mateo J
,
Walsh MF
,
De Sarkar N
,
Abida W
,
Beltran H
,
Garofalo A
,
Gulati R
,
Carreira S
,
Eeles R
et al.
. 2016.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
.
N Engl J Med. 375(5):443-53.
Dardenne E
,
Beltran H
,
Benelli M
,
Gayvert K
,
Berger A
,
Puca L
,
Cyrta J
,
Sboner A
,
Noorzad Z
,
MacDonald T
et al.
. 2016.
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
.
Cancer Cell. 30(4):563-577.
1
(current)
2
next ›
last »